Patent · US Active

Proviral plasmids and production of recombinant adeno-associated virus

US9896665B2 · kind B2 · utility

1Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 2015
Grant dateFeb 20, 2018
Priority date
Expiry dateDec 28, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/90
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Proviral plasmids contain a modular gene expression cassette with one or a combination of (i) a wildtype 5′ AAV2 ITR sequence flanked by unique restriction sites that permit ready removal or replacement of the ITR; (ii) a promoter flanked by unique restriction sites that permit ready removal or replacement of the entire promoter sequence; (iii) a polylinker sequence that permits insertion of a gene coding sequence without modification thereof, wherein the gene is operatively linked to, and under the regulatory control of, the aforementioned promoter; (iv) a bovine growth hormone polyadenylation sequence flanked by unique restriction sites that permit ready removal or replacement of the polyA sequence; and (v) a wildtype 3′ AAV2 ITR sequence flanked by unique restriction sites that permit ready removal or replacement of the 3′ ITR. These plasmids enable rapid manipulation of the components of the cassette, such as rapid mutation and/or replacement of any component, and thereby increase the efficiency of recombinant viral vector, such as rAAV, production.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.